Search research articles
Contact Us
Filters
Showing results (1-10 of 224) with videos related to
Page
of 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Oropharyngeal cancer, human papilloma virus, and clinical trials
Danny Rischin
Seminars in Oncology
|
December 16, 2004
Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?
June Corry, Danny Rischin
Expert Opinion on Pharmacotherapy
|
December 4, 2003
Merkel cell carcinoma--current therapeutic options
Michael Poulsen, Danny Rischin
The Lancet. Oncology
|
January 15, 2011
Induction chemotherapy in head and neck cancer: closer to an answer?
June Corry, Danny Rischin
Hematology/Oncology Clinics of North America
|
November 18, 2008
Sinonasal malignancies of neuroendocrine origin
Danny Rischin, Andrew Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Elusive goal of targeting tumor hypoxia for therapeutic gain
Lester Peters, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer
Benjamin Solomon, Danny Rischin
The Medical Journal of Australia
|
March 31, 2022
In-transit cutaneous squamous cell carcinoma
Luke S McLean, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: where does the chemotherapy piece fit?
Danny Rischin, Lester J Peters
Lancet (London, England)
|
January 24, 2026
Adjuvant nivolumab for resected high-risk head and neck cancer
Annette M Lim, Danny Rischin
Page
of 23
Search research articles
Search
Showing results (1-10 of 224) with videos related to
Sort By:
Page
of 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Oropharyngeal cancer, human papilloma virus, and clinical trials
Danny Rischin
Seminars in Oncology
|
December 16, 2004
Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?
June Corry, Danny Rischin
Expert Opinion on Pharmacotherapy
|
December 4, 2003
Merkel cell carcinoma--current therapeutic options
Michael Poulsen, Danny Rischin
The Lancet. Oncology
|
January 15, 2011
Induction chemotherapy in head and neck cancer: closer to an answer?
June Corry, Danny Rischin
Hematology/Oncology Clinics of North America
|
November 18, 2008
Sinonasal malignancies of neuroendocrine origin
Danny Rischin, Andrew Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Elusive goal of targeting tumor hypoxia for therapeutic gain
Lester Peters, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer
Benjamin Solomon, Danny Rischin
The Medical Journal of Australia
|
March 31, 2022
In-transit cutaneous squamous cell carcinoma
Luke S McLean, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2002
The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: where does the chemotherapy piece fit?
Danny Rischin, Lester J Peters
Lancet (London, England)
|
January 24, 2026
Adjuvant nivolumab for resected high-risk head and neck cancer
Annette M Lim, Danny Rischin
Page
of 23